Second generation hepatitis C virus antibody-positive rate in children: Investigation of the route of hepatitis C virus infection in children with no history of transfusion

Pediatrics International

Volumn 39, Issue 5, 1997, Pages 550-555

  Maniwa, Hiroko ^a   Miyake, Yoshishige ^a   Oda, Takaya ^a   Li, Rou ^a   Yokoyama, Takao ^a   Sugiyama, Kohachiro ^a  

^a NAGOYA CITY UNIV MEDICAL SCHOOL   (Japan)

Author keywords

Casein antibodies; Hepatitis C; Second generation hepatitis C virus antibody

Indexed keywords

HEPATITIS C ANTIBODY;

ADOLESCENT; ANTIGEN ANTIBODY COMPLEX; ARTICLE; BLOOD TRANSFUSION; CHILD; DISEASE TRANSMISSION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; NEWBORN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; VIRUS INFECTION;

ADOLESCENT; ANTIBODIES, VIRAL; CASEINS; CHILD; CHILD, PRESCHOOL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FALSE POSITIVE REACTIONS; HEPACIVIRUS; HEPATITIS C; HUMANS; INFANT; POLYMERASE CHAIN REACTION; RNA, VIRAL;

EID: 0030774782     PISSN: 13288067     EISSN: 1442200X     Source Type: Journal    
DOI: 10.1111/j.1442-200X.1997.tb03639.x     Document Type: Article

References (25)

1. Tanaka E., Kiyosawa K., Sodeyama T. et al. Prevalence of antibody to hepatitis C virus in Japanese schoolchildren: Comparison with adult blood donors. Am. J. Trop. Med Hyg. 1992; 46: 460–4.
2. Watanabe J., Minegishi K., Mitsumori T. et al. Prevalence of anti-HCV antibody in blood donors in the Tokyo area. Vox Sang 1990; 59: 86–8.
3. Nishioka K. Epidemiological and clinical significance of HCV antibody—future problems. Jpn. J. Clin. Med. 1991; 49: 267–72.
4. Ikeda S., Uchida M., Fukumoto S., Shimada Y. Prevalence of HCV antibodies from mass survey in Shimane Prefecture. Jpn. J. Clin. Med. 1991; 49: 378–82.
5. Hayashi J., Yoshimura E., Nabeshima A. et al. Seroepidemiology of hepatitis C virus infection in hemodialysis patients and the general population in Fukuoka and Okinawa, Japan. J. Gastroenterol. 1994; 29: 276–81.
6. Yamaguchi K., Kiyokawa H., Machida J., Obayashi A., Nojiri N., Ueda S. Seroepidemiology of hepatitis C virus infection in Japan and HCV infection in haemodialysis patients. FEMS Microbiol Rev. 1994; 14: 253–8.
7. Tanaka H., Hiyama T., Tsukuma H. et al. Prevalence of second generation antibody to hepatitis C virus among voluntary blood donors in Osaka, Japan. Cancer Causes Control 1994; 5: 409–13.
8. Nishioka K., Watanabe J., Furuta S. et al. Antibody to the hepatitis C virus in acute hepatitis and chronic liver diseases in Japan. Liver 1991; 11: 65–70.
9. Saito M., Hasegawa A., Kashiwakuma T. et al. Performance of an enzyme-linked immunosorbent assay system for antibodies to hepatitis C virus with two new antigens (c11/c7). Clin. Chem. 1992; 38: 2434–9.
10. Shibayama T., Tanaka S., Tanaka E., Kiyosawa K., Kohara M., Hattori N. Clinical evaluation of C-11/C7 blot method and clinical aspects of non A non B liver disease. J. Med. Technol. 1994; 38: 255–60.
11. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 1987; 162: 156–9.
12. Tsuboi T., Inagaki H., Kawabe Y., Matsumoto H., Sugiyama K., Wada Y. Detection of hepatitis C virus genome in children with non-A, non-B chronic hepatitis associated with blood transfusion. J. Jpn. Pediatr. Soc. 1992; 96: 2043–7.
13. Okamoto H., Okada S., Sugiyama Y. et al. The 5′-terminal sequence of the hepatitis C virus genome. Jpn. J. Exp. Med. 1990; 60: 167–77.
14. Okamoto H., Sugiyama Y., Okada S. et al. Typing hepatitis C virus by polymerase chain reaction with type-specific primers: Application to clinical surveys and tracing infectious sources. J. Gen. Virol. 1992; 73: 673–9.
15. Engvall E., Perlmann P. Enzyme-linked immunosorbent assay, ELISA. Quantitation of specific antibodies by enzyme-labeled anti-immunoglobulin in antigen-coated tubes. J. Immunol. 1972; 109: 129–35.
16. Tanaka J., Yoshizawa H. Epidemiology of hepatitis virus B and C. J. Clin. Exp. Med. 1994; 171: 959–64.
17. Watanabe J., Matsumoto C., Fujimura K. et al. Predictive value of screening tests for persistent hepatitis C virus infection evidenced by viraemia. Vox Sang 1993; 65: 199–203.
18. Sugishita C., Sakinada N., Shimotohno K., Ohkoshi S. Hepatitis C virus infection among healthy schoolchildren and non-A non-B hepatitis patients. J. Clin. Exp. Med. 1990; 154: 785–6.
19. Tani Y., Hayashi J., Nakashima T. et al. State of hepatitis C virus infection in childhood. J. Jpn. Assoc. Infect. Dis. 1994; 68: 588.
20. Moriya T., Sasaki F., Mizui M. et al. Transmission of hepatitis C virus from mothers to infants: its frequency and risk factors revisited. Biomed. Pharmacother. 1995; 49: 59–64.
21. Okamoto H., Kurai K., Okada S. et al. Full-length sequence of a hepatitis C virus genome having poor homology to reported isolates: comparative study of four distinct genotypes. Virology 1992; 188: 331–341.
22. Okamoto H., Mishiro S. Genetic heterogeneity of hepatitis C virus. Intervirology 1994; 37: 68–76.
23. Ikeda Y., Toda G., Hashimoto N., Kurokawa K. Antibody to superoxide dismutase, autoimmune hepatitis, and antibody tests for hepatitis C virus. Lancet 1990; 335: 1345–6.
24. Onji M., Kikuchi T., Michitaka K., Saito I., Miyamura T., Ohta Y. Detection of hepatitis C virus antibody in patients with autoimmune hepatitis and other chronic liver diseases. Gastroerol. Jpn. 1991; 26: 182–6.
25. Fujisawa T., Inui A., Komatsu H., Onoue M. Treatment of children with chronic hepatitis C with IFN. Jpn. J. Clin. Med. 1995; 53: 841–6.